About Nyg Pharmaceuticals Private Limited
Data last updated:
Nyg Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 07 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC314046. Its GSTIN is 07AAFCN5320G1ZP (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.08 Lakh. It is led by directors including Satpal Singh Gulia and Sunil Chhikara.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 2161/T – 6 Ground Floor Lal Rattan Bldg Main Patel Road West Patel Nagar, New Delhi, Delhi, India – 110008.
As per the financials filed for FY 2026, the company reported a revenue of ₹32.56 Lakh, a growth of 127% compared to the previous year. For the same year it recorded a net profit of ₹2.7 Lakh (net margin 8.3%) and EBITDA of ₹3.87 Lakh (EBITDA margin 11.9%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 1% over five years.
The company is associated with 1 brand: NygPharma.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nygpharma.com.
Company details
Contact details
Nyg Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Social Media
- Registered Address2161/T – 6 Ground Floor Lal Rattan Bldg Main Patel Road West Patel Nagar, New Delhi, Delhi, India – 110008
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Nyg Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Nyg Pharmaceuticals operates one associated brand: NygPharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical brands for diabetology, vitamins, and cardiology with patient education programs. | nygpharma.com |
Business activity
The main business activity of Nyg Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Nyg Pharmaceuticals Private Limited, buy the company report.
Financials of Nyg Pharmaceuticals Private Limited
FY 2026 filings availableNyg Pharmaceuticals Private Limited reported revenue of ₹32.56 Lakh (up 127% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 127% growth in the latest year. EBITDA rose 224% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹32.56 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.87 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.7 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.9% | ||||
| Net Profit Margin | 8.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nyg Pharmaceuticals Private Limited, buy the company report.
Board of directors of Nyg Pharmaceuticals Private Limited
Nyg Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satpal Singh Gulia Also directs: Margaret Chhikara Real Estate LLP, Bobby Chhikara Real Estate LLP, RDDK Developers Private Limited and 5 more | Director | 07 Mar 2017 | 9 Years 8 Months | Current |
| Sunil Chhikara | Director | 07 Mar 2017 | 9 Years 8 Months | Current |
| Anil Kumar Also directs: Uttarapath Foods Private Limited, Chef Bobby Foods Private Limited, Rhubarb Foods Private Limited and 3 more | Director | 07 Mar 2017 | 9 Years 8 Months | Current |
Auditor
Nyg Pharmaceuticals Private Limited is audited by Neeraj Bhagat & Co. for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Neeraj Bhagat & Co. | FY 2026 | 014949N |
Shareholding
The shareholding of Nyg Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nyg Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nyg Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nyg Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nyg Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCN5320G1ZP | Delhi | Active | 28 May 2018 |
To see the full GST registrations and return filing status of Nyg Pharmaceuticals Private Limited, buy the company report.
Recent activity
Nyg Pharmaceuticals Private Limited has 3 board changes on record since 2017: 3 appointments. The latest: Anil Kumar was appointed as Director on 07 Mar 2017.
Frequently asked questions
Nyg Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 07 March 2017 (9+ years old) and is registered under CIN U74999DL2017PTC314046.
Nyg Pharmaceuticals has 3 current directors:
- Satpal Singh Gulia - Director
- Sunil Chhikara - Director
- Anil Kumar - Director
The latest financial statements of Nyg Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Nyg Pharmaceuticals is 07AAFCN5320G1ZP, registered in Delhi.
The CIN (Corporate Identification Number) of Nyg Pharmaceuticals is U74999DL2017PTC314046. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nyg Pharmaceuticals was incorporated on 07 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Anil Kumar was appointed as Director on 07 Mar 2017. Satpal Singh Gulia was appointed as Director on 07 Mar 2017. Sunil Chhikara was appointed as Director on 07 Mar 2017.
Nyg Pharmaceuticals can be reached through the website nygpharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Nyg Pharmaceuticals is at 2161T – 6 Ground Floor Lal Rattan Bldg Main Patel Road West Patel Nagar, New Delhi, Delhi, India – 110008.
Nyg Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
